ACE2 Peptide Fragment Interaction with Different S1 Protein Sites

Area of Science:

• Biochemistry
• Virology
• Molecular Biology

Background:

• SARS-CoV-2 (coronavirus) utilizes its spike protein S1 to bind angiotensin-converting enzyme 2 (ACE2) on host cells for viral entry.
• The ACE2 α1 domain contains the primary binding site for the SARS-CoV-2 S1 protein.

Purpose of the Study:

• To investigate the effect of a specific peptide (QAKTFLDKFNHEAEDLFYQ) on the kinetics of SARS-CoV-2 spike protein S1 binding to ACE2.
• To characterize the interaction mechanism between the virus and its host cell, aiming to identify novel antiviral intervention strategies.

Main Methods:

• Bio-layer interferometry was employed to measure the kinetics of S1-ACE2 complex formation in the presence of varying peptide concentrations.
• Kinetic analysis of S1-ACE2 complex dissociation was performed after preincubation of the peptide with either S1 protein or ACE2.

Main Results:

• The peptide QAKTFLDKFNHEAEDLFYQ inhibited the formation of the S1-ACE2 complex when preincubated with the S1 protein.
• Preincubation of the peptide with S1 protein led to stabilization of the S1-ACE2 complex, with effects dependent on peptide concentration and preincubation time.
• Computational mapping revealed two additional binding sites on the S1 protein surface, distinct from the main receptor-binding domain.

Conclusions:

• The findings suggest the formation of a ternary complex involving S1, ACE2, and the peptide, indicating potential allosteric modulation or alternative binding sites.
• The study highlights the potential of short, peptide-derived inhibitors for developing new strategies to combat viral infections by disrupting virus-host interactions.